Influence of erythropoietin treatment on dialyzer reuse

Blood Purification

Volumn 15, Issue 2, 1997, Pages 77-83

  Kes, Petar ^a   Reiner, Deljko ^b   Starčević, Boris ^a   Ratković Gusić, Iva ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Adequacy of dialysis; Dialyzer reuse; Hemodialysis; Nutrition; Recombinant human erythropoietin

Indexed keywords

HEPARIN; PERACETIC ACID; RECOMBINANT ERYTHROPOIETIN; UREA;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL;

ADULT; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 0030941685     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170319     Document Type: Article

References (23)

1. Zachec P. Van Rompuy W: Correcting the anemia of end-stage renal failure with recombinant human erythropoietin: The Benelux experience. Erythropoiesis 1994;5:51-57.
2. Sundal E, Kacser U: Correction of anemia of chronic renal failure with r-HuEPO: Safety and efficiency of one year's treatment in European multicentre study of 150 hemodialysis-dependent patients. Nephrol Dial Transplant 1989,4:979-987.
3. Abraham PA: Practical approach to initiation of recombinant human erythropoietin therapy and prevention and management of adverse effects. Am J Nephrol 1990: 10(suppl):7—14.
4. Schaefer RM. Morl EH. Massry SG: Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol 1989:9:353-362.
5. Farrell PC. Eschbach JW. Vivro JE. et al: Hemodialyzer reuse: Estimation of area loss from clearance data. Kidney Int 1974:5:446-450.
6. Lcypoldt JK: Fouling of ultrafiltration and hemodialysis membranes by plasma proteins. Blood Purif 1994:12:285-291.
7. Association of the Advancement of Medical Instrumentation: Reuse of hemodialyzers. AAMI RD47R-1992:1-55.
8. Macdougall IC. Hutton DR. Cavill J: Treating renal anaemia with recombinant human erythropoietin: Practical guidelines and a clinical algorithm. Br Med J 1990:300:655-659.
9. Puretic Z., Kes P., Cala S, Bosit B: Racionalna primjena eritropoetina udijali/.i. Dialyse Journal HR 1994: 1:8-9.
10. Sargent JA, Gotch FA: The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int 1975;7(suppl 2):35-44.
11. Gagnon RF. Kavc M: Dialvzer performance over prolonged reuse. Clin Nephrol 1985:24:21-27.
12. Kashaviah PR. Constantin! EG. Luchmann DA. Shapiro FL: Dialyz-er ultrafiltration coefficients - Comparison between in vitro and in vivo values. Artif Organs 1982:6:23-26.
13. Glantz SA: Primer in Biostatistics. New York. McGraw-Hill. 1987.
14. Kaupke CJ. Vaziri ND. Samson JR. Atkins K: Effect of erythropoietin therapy on diet and dialysis clearances in hemodialysis patients. Int J Artif Organs 1990:13:218-222.
15. Veys N. Vanholder R. De Cuyper K. Ringoir S: Influence of erythropoietin of dialvzer reuse, heparin need, and urea kinetics in maintenance hemodialysis patients. Am J Kidney Dis 1994:23:52-59.
16. Movilli E., Cancarini GC, Mobclloni S, et al: The role of hematocrit in efficiency of dialysis. Blood Purif 1990:8:183—189.
17. Casati S. Campisc M. C'rcpaldi M: Hemodialysis efficiency after longterm treatment with recombinant human erythropoietin. Nephrol Dial Transplant 1989:4:718-720.
18. Spinowitz BS. Arslanian J, Charytan C. et al: Impact of poietin beta on dialvzer clearance and heparin requirements. Am J Kidney Dis 1991: 18:668-673.
19. Farrell PC. Grib NL. Popovich RP. et al: A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects. Trans Am Soc Artif Intent Organs 1972:18:268-270.
20. Wirtz JJJM, van Esser WJ, Hamu-lyak K, et al: The effect of recombinant human erythropoietin on hemostasis and fibrinolysis in hemodialysis patients. Clin Nephrol 1992; 38:277-282.
21. Macdougall IC. Davies ME. Hallett J. et al: Coagulation studies and fistula blood flow during erythropoietin therapy in hemodialysis patients. Nephrol Dial Transplant 1991:6: 862-867.
22. Van Gcclen JA., Nube M.I, Zuurbicr PA: Influence of erythropoietin treatment on urea kinetic parameters in hemodialysis patients. Clin Nephrol 1991:35:165-170.
23. Canaud B. Bouloux C. Rivory JP. et al: Erythropoietin-induced changes in protein nutrition: Quantitative assessment by urea kinetic modelling analysis. Blood Purif 1990:8: 301-308.